If there remains a need, and a clinical and economic rationale, for COVID-19 vaccination, why is vaccine inequity so persistent over time?

PEPFAR’s new strategy—to be released in final form later this year—focuses on how to accelerate progress toward epidemic control amidst continued impacts from COVID-19, while also strengthening core health system functions as well as partnership and coordination efforts; this is precisely what the c...

At the July G20 meeting of finance ministers and central bank governors, a panel of experts (of which I was one) presented their report on the capital adequacy of the MDBs. Why care? the answer, quite simply, is that hundreds of billions of dollars are at stake. As with any bank, small changes in th...

On this first episode of new CGD podcast series Pandemic Proof, co-hosts Amanda Glassman and Javier Guzman take stock of where things stand on the COVID-19 pandemic and discuss global priorities to strengthen capacity for pandemic preparedness and response. Victor Dzau, President of the National Aca...

Few would question that building productive infrastructure has to be at the center of development goals, energy access, food security, and combatting and adapting to climate change. We just saw G7 countries make a bold commitment to infrastructure, launching the Partnership for Global Infrastructure...

Policy-based guarantees (PBGs) have long been a multilateral development bank (MDB) instrument in search of a purpose. PBGs—a credit enhancement for sovereign market borrowing—have been around for decades but their uptake has been limited. In most instances, they have proven remarkably effective in ...

In this blog, I examine why policymakers should ensure that inflation does not erode corrective taxes on killer products and make them more affordable. Using a survey of recent health tax measures, I show that some countries have ensured that health taxes are stepped up while most have hesitated, an...